Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-Current DebtOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Inventory: 2020-2025

Historic Change in Inventory for Legend Biotech (LEGN) over the last 5 years, with Sep 2025 value amounting to $5.4 million.

  • Legend Biotech's Change in Inventory rose 205.75% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year increase of 52.80%. This contributed to the annual value of -$17.2 million for FY2024, which is 35.43% down from last year.
  • As of Q3 2025, Legend Biotech's Change in Inventory stood at $5.4 million, which was up 292.72% from -$2.8 million recorded in Q2 2025.
  • Legend Biotech's 5-year Change in Inventory high stood at $5.4 million for Q3 2025, and its period low was -$6.3 million during Q4 2024.
  • In the last 3 years, Legend Biotech's Change in Inventory had a median value of -$3.2 million in 2023 and averaged -$2.8 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first slumped by 4,433.04% in 2022, then spiked by 205.75% in 2025.
  • Legend Biotech's Change in Inventory (Quarterly) stood at -$115,000 in 2021, then plummeted by 4,433.04% to -$5.2 million in 2022, then grew by 28.99% to -$3.7 million in 2023, then plummeted by 69.23% to -$6.3 million in 2024, then spiked by 205.75% to $5.4 million in 2025.
  • Its Change in Inventory stands at $5.4 million for Q3 2025, versus -$2.8 million for Q2 2025 and -$3.2 million for Q1 2025.